Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.

An accurate and sensitive liquid chromatography-electrospray ionization/multi-stage mass spectrometry (LC-ESI/MS/MS(n)) technique has been developed for the characterization and quantification of 2'-deoxyguanosine (dG) adducts of the dietary mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). PhIP is an animal and potential human carcinogen that occurs in grilled meats. Following enzymatic digestion and adduct enrichment by solid-phase extraction (SPE), PhIP-DNA adducts were analyzed by MS/MS and MS(n) scan modes on a 2-D linear quadrupole ion trap mass spectrometer (QIT/MS). The major DNA adduct, N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (dG-C8-PhIP), was detected in calf thymus (CT) DNA modified in vitro with a bioactivated form of PhIP and in the colon and liver of rats given PhIP as part of the diet. The lower limit of detection (LOD) was 1 adduct per 10(8) DNA bases, and the limit of quantification (LOQ) was 3 adducts per 10(8) DNA bases in both MS/MS and MS(3) scan modes, using 27 microg of DNA for analysis. Measurements were based on isotope dilution with the internal standard, N-(deoxyguanosin-8-yl)-2-amino-1-(trideutero)methyl-6-phenylimidazo[4,5-b]pyridine (dG-C8-[2H3C]-PhIP). The selected reaction monitoring (SRM) scan mode in MS/MS was employed to monitor the loss of deoxyribose (dR) from the protonated molecules of the adducts ([M + H - 116]+). The consecutive reaction monitoring (CRM) scan modes in MS(3) and MS(4) were used to measure and further characterize product ions of the aglycone ion (BH2+) (Guanyl-PhIP). The MS(3) scan mode was effective in eliminating isobaric interferences observed in the MS/MS scan mode and resulted in an improved signal-to-noise (S/N) ratio. Moreover, the product ion spectra obtained by the MS(n) scan modes provided rich structural information about the adduct and were used to corroborate the identity of dG-C8-PhIP. In addition, an isomeric dG-PhIP adduct was detected in vivo. This LC-ESI/MS/MS(n) method is the first reported application on the use of the MS(3) scan mode for the analysis of DNA adducts in vivo.

[1]  I. Blair,et al.  Quantification of benzo[a]pyrene diol epoxide DNA-adducts by stable isotope dilution liquid chromatography/tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[2]  S. Hecht,et al.  Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2006, Chemical research in toxicology.

[3]  M. Lovell,et al.  Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry. , 2006, Chemical research in toxicology.

[4]  J. Swenberg,et al.  LC/MS/MS Method for the Quantitation of trans-2-Hexenal-Derived Exocyclic 1,N2-Propanodeoxyguanosine in DNA , 2006 .

[5]  R. Julian,et al.  Comparison of the Paul ion trap to the linear ion trap for use in global proteomics , 2006, Proteomics.

[6]  P. Farmer,et al.  Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. , 2006, Carcinogenesis.

[7]  Dietrich A. Volmer,et al.  Ion suppression: A major concern in mass spectrometry , 2006 .

[8]  J. Swenberg,et al.  LC/MS/MS method for the quantitation of trans-2-hexenal-derived exocyclic 1,N(2)-propanodeoxyguanosine in DNA. , 2006, Chemical research in toxicology.

[9]  Vicente Andreu and Yolanda Pico.  Liquid Chromatography-Ion Trap-Mass Spectrometry and its Application to Determine Organic Contaminants in the Environment and Food , 2005 .

[10]  P B Farmer,et al.  DNA adducts: mass spectrometry methods and future prospects. , 2005, Toxicology and applied pharmacology.

[11]  M. Lovell,et al.  Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. , 2005, Analytical chemistry.

[12]  S. J. Culp,et al.  High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts. , 2005, Chemical research in toxicology.

[13]  F. Kadlubar,et al.  Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. , 2005, Chemical research in toxicology.

[14]  D. Phillips,et al.  Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans. , 2004, Journal of the National Cancer Institute.

[15]  T. Sugimura,et al.  Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.

[16]  Paul Vouros,et al.  Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  R. Fanelli,et al.  Genetic polymorphisms and modulation of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐DNA adducts in human lymphocytes , 2003, International journal of cancer.

[18]  A. Antunes,et al.  Differentiation of isomeric C8-substituted alkylaniline adducts of guanine by electrospray ionization and tandem quadrupole ion trap mass spectrometry , 2003, Journal of the American Society for Mass Spectrometry.

[19]  M. Churchwell,et al.  DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. , 2003, Chemical research in toxicology.

[20]  G. Sabbioni,et al.  Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. , 2003, Chemical research in toxicology.

[21]  Tomoyuki Shirai,et al.  Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[23]  G. Casale,et al.  Extraction and purification of depurinated benzo[a]pyrene-adducted DNA bases from human urine by immunoaffinity chromatography coupled with HPLC and analysis by LC/quadrupole ion-trap MS. , 2003, Chemical research in toxicology.

[24]  J. Swenberg,et al.  Applications of mass spectrometry for quantitation of DNA adducts. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  M. Senko,et al.  A two-dimensional quadrupole ion trap mass spectrometer , 2002, Journal of the American Society for Mass Spectrometry.

[26]  P. Vouros,et al.  Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry. , 2002, Chemical research in toxicology.

[27]  B. Green,et al.  Carcinogen–DNA adducts in human breast epithelial cells , 2002, Environmental and molecular mutagenesis.

[28]  N. Spooner,et al.  Reduction of signal suppression effects in ESI-MS using a nanosplitting device. , 2001, Analytical chemistry.

[29]  P. Vouros,et al.  Quantification of the heterocyclic aromatic amine DNA adduct N-(deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f]quinoline in livers of rats using capillary liquid chromatography/microelectrospray mass spectrometry: a dose-response study. , 2001, Analytical chemistry.

[30]  K. Turteltaub,et al.  Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts , 2001 .

[31]  M. Churchwell,et al.  Quantification of etheno-DNA adducts using liquid chromatography, on-line sample processing, and electrospray tandem mass spectrometry. , 2000, Chemical research in toxicology.

[32]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[33]  A. Boobis,et al.  Mass spectrometric detection and measurement of N2-(2'-deoxyguanosin-8-yl)PhIP adducts in DNA. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[34]  T. Sugimura,et al.  Contents in foods, beverages and tobacco. , 2000 .

[35]  杉村 隆,et al.  Food borne carcinogens : heterocyclic amines , 2000 .

[36]  M. McManus,et al.  Genetically modified Chinese hamster ovary cells for investigating sulfotransferase‐mediated cytotoxicity and mutation by 2‐amino‐1‐methyl‐6‐ phenylimidazo[4,5‐b]pyridine , 2000, Environmental and molecular mutagenesis.

[37]  P. Vouros,et al.  Determination of in vitro- and in vivo-formed DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline by capillary liquid chromatography/microelectrospray mass spectrometry. , 1999, Chemical research in toxicology.

[38]  R. Santella.  Immunological methods for detection of carcinogen-DNA damage in humans. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  M. Churchwell,et al.  Quantitative analysis of 4-aminobiphenyl-C8-deoxyguanosyl DNA adducts produced in vitro and in vivo using HPLC-ES-MS. , 1999, Carcinogenesis.

[40]  D. Phillips,et al.  Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. , 1999, Mutagenesis.

[41]  S. Venitt,et al.  Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. , 1999, Carcinogenesis.

[42]  E. Snyderwine,et al.  DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. , 1999, Carcinogenesis.

[43]  M. Manns,et al.  UDP-glucuronosyltransferase activity in human liver and colon. , 1999, Gastroenterology.

[44]  H. Suzuki,et al.  An unusual DNA adduct derived from the powerfully mutagenic environmental contaminant 3-nitrobenzanthrone. , 1998, Chemical research in toxicology.

[45]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[46]  E. Snyderwine,et al.  Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat and nonhuman primates. , 1997, Mutation research.

[47]  J. Swenberg,et al.  DNA adducts: biological markers of exposure and potential applications to risk assessment. , 1996, Mutation research.

[48]  P. Vouros,et al.  Determination of in vitro formed DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine using capillary liquid chromatography/electrospray ionization/tandem mass spectrometry. , 1995, Chemical research in toxicology.

[49]  R. Sinha,et al.  High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. , 1995, Cancer research.

[50]  K. Turteltaub,et al.  Heterogeneous DNA adduct formation in vitro by the acetylated food mutagen 2-(acetoxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine: a fluorescence spectroscopic study. , 1995, Chemical Research in Toxicology.

[51]  H. Bartsch,et al.  Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. , 1994, Chemical research in toxicology.

[52]  B. Ketterer,et al.  Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. , 1994, Cancer research.

[53]  H. Marquardt,et al.  32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. , 1994, Carcinogenesis.

[54]  T. Sugimura,et al.  Detection of Guanine‐C8‐2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine Adduct as a Single Spot on Thin‐layer Chromatography by Modification of the 32P‐Postlabeling Method , 1994, Japanese journal of cancer research : Gann.

[55]  R. Giese,et al.  Methods development toward the measurement of polyaromatic hydrocarbon-DNA adducts by mass spectrometry. , 1993, Research report.

[56]  S. Manabe,et al.  Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in beer and wine. , 1993, Carcinogenesis.

[57]  C. R. Herzog,et al.  Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats. , 1992, Cancer letters.

[58]  J. Lay,et al.  Mass spectrometry for the analysis of carcinogen-DNA adducts , 1992 .

[59]  F. Beland,et al.  DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. , 1992, Chemical research in toxicology.

[60]  J. Lay,et al.  Identification of N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. , 1992, Chemical research in toxicology.

[61]  W. Humphreys,et al.  Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Lay,et al.  Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. , 1992, Chemical research in toxicology.

[63]  J. Larsen,et al.  Reaction of the N2-acetoxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) with 2'-deoxyguanosine and DNA. Synthesis and identification of N2-(2'-deoxyguanosin-8-yl)-PhIP. , 1992, Carcinogenesis.

[64]  M. Butler,et al.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. , 1991, Carcinogenesis.

[65]  S. Manabe,et al.  Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. , 1991, Carcinogenesis.

[66]  R. Cooks,et al.  Ion trap mass spectrometry , 1991 .

[67]  W. Paul.  Electromagnetic Traps for Charged and Neutral Particles (Nobel Lecture) , 1990 .

[68]  J. Southon,et al.  Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  R. Jankowiak,et al.  Fluorescence line-narrowing spectroscopy in the study of chemical carcinogenesis. , 1989, Analytical chemistry.

[71]  T. A. Avitts,et al.  Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. , 1989, Journal of the National Cancer Institute.

[72]  R. Floyd,et al.  Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. , 1986, Free radical research communications.

[73]  M. Schurdak,et al.  Postlabeling methods for carcinogen-DNA adduct analysis. , 1985, Environmental health perspectives.

[74]  J. Weaver,et al.  32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. , 1985, Carcinogenesis.

[75]  Roger A. Mineur.  Thermo Electron CORPORATION. , 1982, Environmental science & technology.

[76]  D. MacDougall,et al.  Guidelines for data acquisition and data quality evaluation in environmental chemistry , 1980 .

[77]  J. Groopman,et al.  Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. , 1980, Cancer research.

[78]  E. Miller.  Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.